Fair Value (Tables)

12 Months Ended

Oct. 02, 2015

Assets and Liabilities Measured at Fair Value on a Recurring Basis

In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.



	Fair Value Measurement Using
Type of Instruments	Quoted Prices in Active Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)			Total Balance
(In millions)
Assets at October 2, 2015:
Available-for-sale securities:
Corporate debt securities	$	—	$	8.4	$	83.9		$	92.3
Non-U.S. government security	—		0.7		—			0.7
Total assets measured at fair value	$	—	$	9.1	$	83.9		$	93.0

Liabilities at October 2, 2015:
Contingent consideration	$	—	$	—	$	(4.1	)	$	(4.1	)
Total liabilities measured at fair value	$	—	$	—	$	(4.1	)	$	(4.1	)

Assets at September 26, 2014:
Available-for-sale securities:
Corporate debt securities	$	—	$	—	$	75.6		$	75.6
Derivative assets	—		1.5		—			1.5
Total assets measured at fair value	$	—	$	1.5	$	75.6		$	77.1

Liabilities at September 26, 2014:
Contingent consideration	$	—	$	—	$	(7.5	)	$	(7.5	)
Total liabilities measured at fair value	$	—	$	—	$	(7.5	)	$	(7.5	)

Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis

The following table presents the reconciliation for all assets and liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):



(In millions)	CPTC Loans			Contingent Consideration			Option to Purchase a Privately-Held Company
Balance at September 27, 2013	$	62.7		$	(2.5	)	$	1.4
Additions ⁽¹⁾	51.0			(6.2		)	—
Sale of a portion of CPTC Loans ⁽²⁾	(38.1		)	—			—
Settlements ⁽³⁾	—			0.5			—
Change in fair value recognized in earnings	—			0.7			(1.4		)
Balance at September 26, 2014	75.6			(7.5		)	—
Additions ⁽¹⁾	8.3			—			—
Settlements ⁽³⁾	—			3.3			—
Change in fair value recognized in earnings	—			0.1			—
Balance at October 2, 2015	$	83.9		$	(4.1	)	$	—


⁽¹⁾	Amounts reported under CPTC loans include accrued interest.


⁽²⁾	Refer to Note 16, "VPT Loans"


⁽³⁾	Amounts reported under Contingent Consideration represent cash payments to settle contingent consideration liabilities.

Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring BasisFair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table presents the reconciliation for all assets and liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):



(In millions)	CPTC Loans			Contingent Consideration			Option to Purchase a Privately-Held Company
Balance at September 27, 2013	$	62.7		$	(2.5	)	$	1.4
Additions ⁽¹⁾	51.0			(6.2		)	—
Sale of a portion of CPTC Loans ⁽²⁾	(38.1		)	—			—
Settlements ⁽³⁾	—			0.5			—
Change in fair value recognized in earnings	—			0.7			(1.4		)
Balance at September 26, 2014	75.6			(7.5		)	—
Additions ⁽¹⁾	8.3			—			—
Settlements ⁽³⁾	—			3.3			—
Change in fair value recognized in earnings	—			0.1			—
Balance at October 2, 2015	$	83.9		$	(4.1	)	$	—


⁽¹⁾	Amounts reported under CPTC loans include accrued interest.


⁽²⁾	Refer to Note 16, "VPT Loans"


⁽³⁾	Amounts reported under Contingent Consideration represent cash payments to settle contingent consideration liabilities.

Equity Method Investments

For the fiscal year ended September 26, 2014, the Company’s assets that were measured at fair value on a nonrecurring basis are summarized below:



(in millions)	Carrying Value as of September 26, 2014		Total Losses for Fiscal Year 2014
Equity Investment in Augmenix	$	7.3	$	6.3